Medpace Holdings Price to Free Cash Flow Ratio 2014-2025 | MEDP
Historical price to free cash flow ratio values for Medpace Holdings (MEDP) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medpace Holdings Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-14 | 590.09 | 25.79 | |
| 2025-09-30 | 514.16 | $22.88 | 22.47 |
| 2025-06-30 | 313.86 | $18.92 | 16.59 |
| 2025-03-31 | 304.69 | $16.99 | 17.93 |
| 2024-12-31 | 332.23 | $17.88 | 18.59 |
| 2024-09-30 | 333.80 | $16.71 | 19.98 |
| 2024-06-30 | 411.85 | $15.69 | 26.25 |
| 2024-03-31 | 404.15 | $14.86 | 27.19 |
| 2023-12-31 | 306.53 | $12.46 | 24.60 |
| 2023-09-30 | 242.13 | $11.37 | 21.29 |
| 2023-06-30 | 240.17 | $11.38 | 21.11 |
| 2023-03-31 | 188.05 | $11.61 | 16.20 |
| 2022-12-31 | 212.41 | $10.43 | 20.37 |
| 2022-09-30 | 157.17 | $8.55 | 18.37 |
| 2022-06-30 | 149.67 | $7.02 | 21.33 |
| 2022-03-31 | 163.59 | $5.91 | 27.69 |
| 2021-12-31 | 217.64 | $6.24 | 34.90 |
| 2021-09-30 | 189.28 | $7.21 | 26.24 |
| 2021-06-30 | 176.63 | $6.78 | 26.06 |
| 2021-03-31 | 164.05 | $6.23 | 26.34 |
| 2020-12-31 | 139.20 | $6.03 | 23.09 |
| 2020-09-30 | 111.75 | $4.82 | 23.19 |
| 2020-06-30 | 93.02 | $5.00 | 18.59 |
| 2020-03-31 | 73.38 | $5.20 | 14.12 |
| 2019-12-31 | 84.06 | $4.90 | 17.17 |
| 2019-09-30 | 84.04 | $4.50 | 18.67 |
| 2019-06-30 | 65.42 | $4.31 | 15.18 |
| 2019-03-31 | 58.97 | $4.12 | 14.31 |
| 2018-12-31 | 52.93 | $3.81 | 13.90 |
| 2018-09-30 | 59.91 | $3.43 | 17.46 |
| 2018-06-30 | 43.00 | $3.07 | 14.03 |
| 2018-03-31 | 34.91 | $2.80 | 12.46 |
| 2017-12-31 | 36.26 | $2.15 | 16.86 |
| 2017-09-30 | 31.90 | $2.23 | 14.30 |
| 2017-06-30 | 29.00 | $2.73 | 10.61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.622B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.252B | 28.69 |
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 12.99 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| Revvity (RVTY) | United States | $10.513B | 19.36 |
| HealthEquity (HQY) | United States | $8.768B | 35.09 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Avantor (AVTR) | United States | $7.759B | 11.85 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Ardent Health (ARDT) | United States | $1.289B | 4.21 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| Embecta (EMBC) | United States | $0.851B | 4.98 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| Nutex Health (NUTX) | United States | $0.595B | 9.01 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.383B | 5.76 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.024B | 7.21 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |